AnaptysBio has reported that the ARISE-AD trial of its investigational B and T lymphocyte attenuator (BTLA) agonist, ANB032, ...

As previously reported, Guggenheim downgraded Q32 Bio (QTTB) to Neutral from Buy and removed the firm’s prior price target following the ...

Dupilumab treatment improves signs and symptoms of atopic dermatitis (AD) in young children, according to a study published ...

Brittany Lancellotti, DVM, DACVD, offered ways veterinarians can help reduce caregiver burden in clients in an interview at the 2024 Fetch Long Beach conference ...

In allergen-driven models of atopic dermatitis, subcutaneous (SQ) administration of ‘1104 demonstrated comparable performance to intravenous administration (IV)In multiple preclinical models evaluated ...

Jojoba is a seed oil made from a desert shrub. It’s used to restore hair to its optimal state. Learn how to apply jojoba oil ...

In addition to looking better on your vanity, clean brushes actually perform better. Dirt, oil, and makeup buildup can weigh ...

We talked to a licensed esthetician about the trusted, high-tech face masks that'll help fight everything from wrinkles to ...

A promising new approach to taming troublesome skin conditions could be on the horizon thanks to an examination of skin cells.

BMO Capital lowered the firm’s price target on Q32 Bio (QTTB) to $22 from $64 but keeps an Outperform rating on the shares. The company ...

Researchers found that a procalcitonin (PCT)-guided protocol significantly reduces the duration of antibiotic therapy in ...

Evidence indicates that regular coffee consumption in normotensive individuals does not negatively impact cardiovascular ...